Home › Funds › Millennium Management › PCVX
Millennium Management position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)136.62K sh
Reported value held$7.94M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 281.28K | $7.14M | New |
| Q4 2021 | 286.32K | $6.81M | Add |
| Q1 2022 | 262.72K | $6.34M | Reduce |
| Q2 2022 | 566.12K | $12.32M | Add |
| Q3 2022 | 786.32K | $18.87M | Add |
| Q4 2022 | 1.22M | $58.48K | Add |
| Q1 2023 | 1.31M | $49.23K | Add |
| Q2 2023 | 1.22M | $61.13M | Reduce |
| Q3 2023 | 582.87K | $29.71M | Reduce |
| Q4 2023 | 691.43K | $43.42M | Add |
| Q1 2024 | 206.98K | $14.14M | Reduce |
| Q2 2024 | 203.73K | $15.38M | Reduce |
| Q3 2024 | 298.44K | $34.10M | Add |
| Q4 2024 | 276.58K | $22.64M | Reduce |
| Q1 2025 | 494.43K | $18.67M | Add |
| Q2 2025 | 1.14M | $36.93M | Add |
| Q3 2025 | 948.97K | $34.18M | Reduce |
| Q4 2025 | 424.29K | $19.58M | Reduce |
| Q1 2026 | 293.69K | $17.07M | Reduce |
| Q2 2026 | 136.62K | $7.94M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026